These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11398907)

  • 1. Fluoroquinolones: place in ocular therapy.
    Smith A; Pennefather PM; Kaye SB; Hart CA
    Drugs; 2001; 61(6):747-61. PubMed ID: 11398907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
    Diamond JP; White L; Leeming JP; Bing Hoh H; Easty DL
    Br J Ophthalmol; 1995 Jun; 79(6):606-9. PubMed ID: 7626579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomefloxacin is an effective treatment of experimental bacterial keratitis.
    Kowalski RP; Romanowski EG; Yates KA; Gordon YJ
    Cornea; 2001 Apr; 20(3):306-8. PubMed ID: 11322421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lomefloxacin in treatment of infectious eye diseases].
    Maĭchuk IuF; Vakhova ES; Kononenko LA
    Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
    Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial agents in infections of the central nervous system and eye.
    Papastamelos AG; Tunkel AR
    Infect Dis Clin North Am; 1995 Sep; 9(3):615-37. PubMed ID: 7490436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluoroquinolones in ophthalmology: indications and current use].
    Chiquet C; Labetoulle M
    J Fr Ophtalmol; 2008 Oct; 31(8):803-8. PubMed ID: 19107048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
    Cochereau-Massin I; Bauchet J; Marrakchi-Benjaafar S; Saleh-Mghir A; Faurisson F; Vallois JM; Vallee E; Pocidalo JJ
    Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Literature-Based Review and Analysis of the Pharmacodynamics of the Dose Frequency of Topical 0.3% Ciprofloxacin and 0.3% Ofloxacin in the Day-1 Treatment of Bacterial Keratitis.
    Pearce JG; Naunton M; Maddess T
    J Ocul Pharmacol Ther; 2023; 39(1):17-26. PubMed ID: 36454630
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits.
    Hatano H; Inoue K; Shia S; Liping W
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):666-70. PubMed ID: 8109214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposits of topical norfloxacin in the treatment of bacterial keratitis.
    Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J
    Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
    Goldstein MH; Kowalski RP; Gordon YJ
    Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ocular infections with topical antibacterials.
    Leeming JP
    Clin Pharmacokinet; 1999 Nov; 37(5):351-60. PubMed ID: 10589371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
    Cutarelli PE; Lass JH; Lazarus HM; Putman SC; Jacobs MR
    Curr Eye Res; 1991 Jun; 10(6):557-63. PubMed ID: 1893771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis.
    Krustev SZ; Rusenova NV; Haritova AM
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1459-62. PubMed ID: 23937580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.